CAT

The Thrombogram describes the concentration of thrombin in clotting plasma and is therefore a general physiologic function test of the thrombotic hemostatic system. The Calibrated Automated Thrombogram (CAT) measures thrombotic as well as bleeding tendency and can be used to measure any genetic or acquired thrombotic disorder such as AT deficiency or use of oral anticonceptives

• to support the development of antithrombotic drugs such as antiplatelet drugs and direct inhibitors of thrombin.
• to monitor the treatment of hemophilic disorders such as treatment with factor VIII, factor VIIa.
• to monitor the treatment of thrombotic disorders such as treatment with oral anticoagulant drugs (coumarin), any heparin (UFH, Fraxiparin), antiplatelet drugs (Reopro, Clopidogrel) or any combination of drugs.
• to obtain a full picture of the thrombotic tendency of patients at high risk for thrombosis or bleeding.

Click here to find out which biomarkers are available for testing on this platform.